1-丁基-1H-苯并咪唑，CAS 登记号 4886-30-0，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于有机化学品。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
有机化学品
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 1-丁基-1H-苯并咪唑 的 CAS 号：4886-30-0，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
1-butyl-1H-benzimidazole · CAS 4886-30-0 · C11H14N2.
| CAS Registry Number | 4886-30-0 |
|---|---|
| PubChem CID | 410458 |
| Molecular formula | C11H14N2 |
| IUPAC name | 1-butylbenzimidazole |
| Molecular Weight | 174.24 |
|---|---|
| XLogP3 | 2.6 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 3 |
| Exact Mass | 174.115698455 |
| Monoisotopic Mass | 174.115698455 |
| Topological Polar Surface Area | 17.8 |
| Heavy Atom Count | 13 |
| Formal Charge | 0 |
| GHS notification summary | 75% (6 / 8) |
|---|
| GHS notification summary | 75% (6 / 8) |
|---|---|
| Reported hazard statements | H302 (25%), H314 (12.5%), H315 (12.5%), H318 (12.5%), H335 (12.5%), H412 (12.5%) |
This chemical does not meet GHS hazard criteria for 75% (6 of 8) of all reports.
H302 (25%): Harmful if swallowed [Warning Acute toxicity, oral]
1-butylbenzimidazole; 1-butyl-1H-benzimidazole; RefChem:431100; 691-243-7; 4886-30-0; N-butylbenzimidazole; 1-butyl-1H-benzo[d]imidazole; 1H-BENZIMIDAZOLE,1-BUTYL-(9CI); MFCD00464045; 1H-Benzimidazole, 1-butyl-; 1-butyl-1H-1,3-benzodiazole; benzimidazole, 1-n-butyl-; SCHEMBL180261; SCHEMBL293155; SCHEMBL5981819; SCHEMBL7821346
CAS 4886-30-0; molecular formula C11H14N2; molecular weight — g/mol.
1-butylbenzimidazole, 1-butyl-1H-benzimidazole, RefChem:431100, 691-243-7, 4886-30-0, N-butylbenzimidazole.
75% of GHS notifications report no hazard classification (6 of 8).
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.